Literature DB >> 24184248

A molecular mechanism for adrenergic-induced long QT syndrome.

Jie Wu1, Nobu Naiki2, Wei-Guang Ding3, Seiko Ohno2, Koichi Kato2, Wei-Jin Zang4, Brian P Delisle5, Hiroshi Matsuura3, Minoru Horie6.   

Abstract

OBJECTIVES: This study sought to explore molecular mechanisms underlying the adrenergic-induced QT prolongation associated with KCNQ1 mutations.
BACKGROUND: The most frequent type of congenital long QT syndrome is LQT1, which is caused by mutations in the gene (KCNQ1) that encodes the alpha subunit of the slow component of delayed rectifier K(+) current (IKs) channel. We identified 11 patients from 4 unrelated families that are heterozygous for KCNQ1-G269S. Most patients remained asymptomatic, and their resting corrected QT intervals ranged from normal to borderline but were prolonged significantly during exercise.
METHODS: Wild-type (WT) KCNQ1 and/or KCNQ1-G269S (G269S) were expressed in mammalian cells with KCNE1. IKs-like currents were measured in control conditions or after isoproterenol or protein kinase A (PKA) stimulation using the patch-clamp technique. Additionally, experiments that incorporated the phosphomimetic KCNQ1 substitution, S27D, in WT or KCNQ1-G269S were also performed.
RESULTS: The coexpression of WT-KCNQ1 with varying amounts of G269S decreased IKs, shifted the current-voltage I-V relation of IKs to more positive potentials, and accelerated the IKs deactivation rates in a concentration-dependent manner. In addition, the coexpression of G269S and WT blunted the activation of IKs in response to isoproterenol or PKA stimulation. Lastly, a phosphomimetic substitution in G269S did not show an increased IKs.
CONCLUSIONS: G269S modestly affected IKs in control conditions, but it almost completely blunted IKs responsiveness in conditions that simulate or mimic PKA phosphorylation of KCNQ1. This insensitivity to PKA stimulation may explain why patients with G269S mutation showed an excessive prolongation of QT intervals on exercise.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  KCNQ1 mutation; heterologous expression; long QT syndrome; protein kinase A stimulation

Mesh:

Substances:

Year:  2013        PMID: 24184248     DOI: 10.1016/j.jacc.2013.08.1648

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

Review 1.  QT Prolongation and Malignant Arrhythmia: How Serious a Problem?

Authors:  Christos-Konstantinos Antoniou; Polychronis Dilaveris; Panagiota Manolakou; Spyridon Galanakos; Nikolaos Magkas; Konstantinos Gatzoulis; Dimitrios Tousoulis
Journal:  Eur Cardiol       Date:  2017-12

2.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 3.  How personalized heart modeling can help treatment of lethal arrhythmias: A focus on ventricular tachycardia ablation strategies in post-infarction patients.

Authors:  Natalia A Trayanova; Ashish N Doshi; Adityo Prakosa
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-01-09

4.  Physiological Functions, Biophysical Properties, and Regulation of KCNQ1 (KV7.1) Potassium Channels.

Authors:  Michael C Sanguinetti; Guiscard Seebohm
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.

Authors:  Daniel C Bartos; John R Giudicessi; David J Tester; Michael J Ackerman; Seiko Ohno; Minoru Horie; Michael H Gollob; Don E Burgess; Brian P Delisle
Journal:  Heart Rhythm       Date:  2013-11-21       Impact factor: 6.343

6.  A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1.

Authors:  Xiao-Meng Chen; Kai Guo; Hong Li; Qiu-Fen Lu; Chao Yang; Ying Yu; Jian-Wen Hou; Yu-Dong Fei; Jian Sun; Jun Wang; Yi-Xue Li; Yi-Gang Li
Journal:  Heart Vessels       Date:  2018-07-14       Impact factor: 2.037

Review 7.  Exercise Test for Patients with Long QT Syndrome.

Authors:  Cheng-Han Chan; Yu-Feng Hu; Pei-Fen Chen; I-Chien Wu; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

Review 8.  Molecular pathogenesis of long QT syndrome type 1.

Authors:  Jie Wu; Wei-Guang Ding; Minoru Horie
Journal:  J Arrhythm       Date:  2016-01-27

Review 9.  Computational models in cardiology.

Authors:  Steven A Niederer; Joost Lumens; Natalia A Trayanova
Journal:  Nat Rev Cardiol       Date:  2019-02       Impact factor: 32.419

10.  Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.

Authors:  Hendrik Lapp; Tobias Bruegmann; Daniela Malan; Stephanie Friedrichs; Carsten Kilgus; Alexandra Heidsieck; Philipp Sasse
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.